IAC (IAC) Reports Q2 Earnings: What Key Metrics Have to Say

IAC reported mixed Q2 2025 results, with revenue of $586.93 million representing a 38.2% year-over-year decline and missing consensus estimates by 2.53%. Despite the significant top-line contraction, the company posted a strong EPS of $2.57, a substantial increase from $0.01 a year ago and a 956.67% beat against the -$0.30 consensus estimate. While key segments like Search and Emerging & Other experienced considerable revenue declines, adjusted EBITDA for Care.com and Search segments surpassed analyst expectations. Investors should note IAC's stock has underperformed the S&P 500 over the past month and carries a Zacks Rank #4 (Sell), suggesting potential near-term underperformance.

Analysis

IAC's Q2 2025 results present a conflicting picture, defined by a significant top-line contraction juxtaposed with a massive bottom-line beat. The company reported a 38.2% year-over-year revenue decline to $586.93 million, missing consensus estimates by 2.53%. This weakness was broad-based, with the Search segment revenue falling 39.4% YoY to $61.7 million, well below the $77.09 million analyst forecast, and the Emerging & Other segment revenue collapsing 85.2% YoY. In contrast, EPS came in at $2.57, a dramatic reversal from $0.01 in the prior year and a 956.67% positive surprise against the consensus estimate of a -$0.30 loss. This suggests strong operational leverage or non-operational gains, as multiple segments including Care.com and Search delivered Adjusted EBITDA figures that surpassed analyst expectations. Despite the earnings beat, the stock's recent market underperformance (+0.1% vs S&P 500's +0.6% over the past month) and its Zacks Rank #4 (Sell) indicate that investors are weighing the severe revenue deterioration more heavily than the anomalous profitability.

Key Decisions for Investors

• Investors should investigate the source of the extraordinary $2.57 EPS, as its sustainability is questionable given the concurrent 38.2% YoY revenue decline and miss on sales estimates.
• The significant revenue deterioration in the Search (-39.4%) and Emerging & Other (-85.2%) segments warrants caution, suggesting fundamental headwinds that stronger-than-expected Adjusted EBITDA may not be able to offset long-term.
• Given the stock's recent underperformance relative to the S&P 500 and its designation as a Zacks Rank #4 (Sell), it may be prudent to await signs of a revenue stabilization before building a long position, despite the headline earnings beat.